{"transactions":[{"id":1148878,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Interim CEO"}}],"security":"Common Stock","published_at":"2025-05-14T14:28:49.000Z","date":"2025-05-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":4474,"price":12.43,"value":55611.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 10,000 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on December 3, 2024 and (ii) vested on May 13, 2025. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":200019,"source":{"system":"sec-edgar","filing":"0001606498-25-000093","document":"wk-form4_1747247322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000093/wk-form4_1747247322.xml","form_type":"4"}},{"id":1148877,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Interim CEO"}}],"security":"Common Stock","published_at":"2025-05-14T14:28:49.000Z","date":"2025-05-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":19771,"price":12.43,"value":245753.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 44,189 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on October 29, 2024 and (ii) vested on May 13, 2025. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":204493,"source":{"system":"sec-edgar","filing":"0001606498-25-000093","document":"wk-form4_1747247322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000093/wk-form4_1747247322.xml","form_type":"4"}},{"id":1211687,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-11T16:54:56.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":73633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest 30% on March 7, 2026, 30% on March 7, 2027 and 40% on March 7, 2028."}],"balance_after":73633,"derivative":{"exercise_price":15.24,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":73633},"source":{"system":"sec-edgar","filing":"0001606498-25-000052","document":"wk-form4_1741726490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000052/wk-form4_1741726490.xml","form_type":"4"}},{"id":1211686,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-03-11T16:54:56.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":34316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 7, 2026, 1/3 on March 7, 2027 and 1/3 on March 7, 2028. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":224264,"source":{"system":"sec-edgar","filing":"0001606498-25-000052","document":"wk-form4_1741726490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000052/wk-form4_1741726490.xml","form_type":"4"}},{"id":1214603,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-03-10T11:51:06.000Z","date":"2025-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":8485,"price":15.3,"value":129820.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 18,965 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":189948,"source":{"system":"sec-edgar","filing":"0001606498-25-000044","document":"wk-form4_1741621859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000044/wk-form4_1741621859.xml","form_type":"4"}},{"id":1214602,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-03-10T11:51:06.000Z","date":"2025-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":5112,"price":15.3,"value":78213.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 11,424 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":198433,"source":{"system":"sec-edgar","filing":"0001606498-25-000044","document":"wk-form4_1741621859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000044/wk-form4_1741621859.xml","form_type":"4"}},{"id":1219174,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-03-06T14:22:40.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":4642,"price":15.13,"value":70233.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 10,396 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":203545,"source":{"system":"sec-edgar","filing":"0001606498-25-000030","document":"wk-form4_1741288954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000030/wk-form4_1741288954.xml","form_type":"4"}},{"id":1219173,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-03-06T14:22:40.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":6048,"price":15.13,"value":91506.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 12,149 PRSUs which vested on March 4, 2025."}],"balance_after":208187,"source":{"system":"sec-edgar","filing":"0001606498-25-000030","document":"wk-form4_1741288954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000030/wk-form4_1741288954.xml","form_type":"4"}},{"id":1219172,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-03-06T14:22:40.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":12149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total beneficially owned includes 666 shares acquired on December 31, 2024 and 522 shares acquired on June 30, 2024 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":214235,"source":{"system":"sec-edgar","filing":"0001606498-25-000030","document":"wk-form4_1741288954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649825000030/wk-form4_1741288954.xml","form_type":"4"}},{"id":1341378,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-12-05T10:37:22.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest on December 3, 2025, provided that if the Reporting Person's employment is terminated without cause prior to such date, all the TRSUs will vest immediately. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":200898,"source":{"system":"sec-edgar","filing":"0001606498-24-000096","document":"wk-form4_1733413035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000096/wk-form4_1733413035.xml","form_type":"4"}},{"id":1378755,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2024-10-31T15:51:06.000Z","date":"2024-10-29","kind":"grant","planned":false,"acquired":true,"shares":44189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest on October 29, 2025, provided that if the Reporting Person's employment is terminated  without cause prior to such date, all the TRSUs will vest immediately. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":190898,"source":{"system":"sec-edgar","filing":"0001606498-24-000086","document":"wk-form4_1730404259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000086/wk-form4_1730404259.xml","form_type":"4"}},{"id":1567656,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T16:11:46.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":7113,"price":19.09,"value":135787.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 15,861 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each TRSU is the economic equivalent of one share of Common Stock."}],"balance_after":146709,"source":{"system":"sec-edgar","filing":"0001606498-24-000051","document":"wk-form4_1710879090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000051/wk-form4_1710879090.xml","form_type":"4"}},{"id":1567655,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T16:11:46.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1892,"price":19.09,"value":36118.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 4,219 PRSUs which vested on March 18, 2024."}],"balance_after":153822,"source":{"system":"sec-edgar","filing":"0001606498-24-000051","document":"wk-form4_1710879090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000051/wk-form4_1710879090.xml","form_type":"4"}},{"id":1567654,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T16:11:46.000Z","date":"2024-03-18","kind":"exercise","planned":false,"acquired":true,"shares":4219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each PRSU is the economic eqiuvalent of one share of Common Stock."}],"balance_after":155714,"source":{"system":"sec-edgar","filing":"0001606498-24-000051","document":"wk-form4_1710879090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000051/wk-form4_1710879090.xml","form_type":"4"}},{"id":1574331,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-15T11:40:21.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":110,"price":19.16,"value":2107.6,"ownership":{"direct":true},"balance_after":151495,"source":{"system":"sec-edgar","filing":"0001606498-24-000045","document":"wk-form4_1710517212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000045/wk-form4_1710517212.xml","form_type":"4"}},{"id":1574330,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-15T11:40:21.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":808,"price":19.15,"value":15473.2,"ownership":{"direct":true},"balance_after":151605,"source":{"system":"sec-edgar","filing":"0001606498-24-000045","document":"wk-form4_1710517212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000045/wk-form4_1710517212.xml","form_type":"4"}},{"id":1574329,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-15T11:40:21.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":337,"price":19.14,"value":6450.18,"ownership":{"direct":true},"balance_after":152413,"source":{"system":"sec-edgar","filing":"0001606498-24-000045","document":"wk-form4_1710517212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000045/wk-form4_1710517212.xml","form_type":"4"}},{"id":1574328,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-15T11:40:21.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":2231,"price":19.13,"value":42679.03,"ownership":{"direct":true},"balance_after":152750,"source":{"system":"sec-edgar","filing":"0001606498-24-000045","document":"wk-form4_1710517212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000045/wk-form4_1710517212.xml","form_type":"4"}},{"id":1574327,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-15T11:40:21.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":714,"price":19.12,"value":13651.68,"ownership":{"direct":true},"balance_after":154981,"source":{"system":"sec-edgar","filing":"0001606498-24-000045","document":"wk-form4_1710517212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000045/wk-form4_1710517212.xml","form_type":"4"}},{"id":1574326,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-15T11:40:21.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":3800,"price":19.11,"value":72618.0,"ownership":{"direct":true},"balance_after":155695,"source":{"system":"sec-edgar","filing":"0001606498-24-000045","document":"wk-form4_1710517212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000045/wk-form4_1710517212.xml","form_type":"4"}},{"id":1588730,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T17:05:47.000Z","date":"2024-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":5118,"price":19,"value":97242.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of TRSUs awarded to the Reporting Person on March 6, 2023, of which 1/3 vested on March 6, 2024, 1/3 will vest on March 6,  2025 and the remaining 1/3 will vest on March 6, 2026."}],"balance_after":159495,"source":{"system":"sec-edgar","filing":"0001606498-24-000041","document":"wk-form4_1709849135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000041/wk-form4_1709849135.xml","form_type":"4"}},{"id":1588729,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T17:05:47.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":57471,"price":19.14,"value":1099994.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 6, 2025, 1/3 on March 6, 2026 and 1/3 on March 6, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total beneficially owned includes 448 shares acquired on December 31, 2023 and 382 shares acquired on June 30, 2023 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":164613,"source":{"system":"sec-edgar","filing":"0001606498-24-000041","document":"wk-form4_1709849135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000041/wk-form4_1709849135.xml","form_type":"4"}},{"id":1590918,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-06T16:10:24.000Z","date":"2024-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":4991,"price":18.76,"value":93631.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units (TRSUs) awarded to the Reporting Person on March 4, 2022, of which 1/3 vested on March 4, 2023, 1/3 vested on March 4, 2024 and the remaining 1/3 will vest on March 4, 2025."}],"balance_after":106312,"source":{"system":"sec-edgar","filing":"0001606498-24-000028","document":"wk-form4_1709759412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649824000028/wk-form4_1709759412.xml","form_type":"4"}},{"id":1899235,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-09T17:20:47.000Z","date":"2023-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":14710,"price":23.97,"value":352598.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on May 7, 2020 with a 3-year cliff vesting period."}],"balance_after":111303,"source":{"system":"sec-edgar","filing":"0001606498-23-000042","document":"wf-form4_168366723508665.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649823000042/wf-form4_168366723508665.xml","form_type":"4"}},{"id":1940000,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-23T11:31:04.000Z","date":"2023-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":3037,"price":29.62,"value":89955.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025."}],"balance_after":126013,"source":{"system":"sec-edgar","filing":"0001606498-23-000035","document":"wf-form4a_167958545286655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649823000035/wf-form4a_167958545286655.xml","form_type":"4/A","original_submission_date":"2023-03-07"}},{"id":1939999,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-23T11:31:04.000Z","date":"2023-03-06","kind":"grant","planned":false,"acquired":true,"shares":34619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total beneficially owned includes 339 shares acquired on December 30, 2022 and 327 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":129050,"source":{"system":"sec-edgar","filing":"0001606498-23-000035","document":"wf-form4a_167958545286655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649823000035/wf-form4a_167958545286655.xml","form_type":"4/A","original_submission_date":"2023-03-07"}},{"id":1965182,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-07T16:48:44.000Z","date":"2023-03-06","kind":"tax_withholding","acquired":false,"shares":3037,"price":29.62,"value":89955.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025."}],"balance_after":127744,"source":{"system":"sec-edgar","filing":"0001606498-23-000029","document":"wf-form4_167822571073463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649823000029/wf-form4_167822571073463.xml","form_type":"4"}},{"id":1965181,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-07T16:48:44.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":36350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total beneficially owned includes 339 shares acquired on December 30, 2022 and 327 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":130781,"source":{"system":"sec-edgar","filing":"0001606498-23-000029","document":"wf-form4_167822571073463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649823000029/wf-form4_167822571073463.xml","form_type":"4"}},{"id":2065999,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-04T15:55:52.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":4726,"price":27.06,"value":127885.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on January 2, 2020 with a 3-year cliff vesting period."}],"balance_after":93765,"source":{"system":"sec-edgar","filing":"0001606498-23-000003","document":"wf-form4_167286573406397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649823000003/wf-form4_167286573406397.xml","form_type":"4"}},{"id":2343815,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-08T11:28:26.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":30575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 4, 2023, 1/3 on March 4, 2024 and 1/3 on March 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total beneficially owned includes 184 shares acquired on December 31, 2020, 236 shares acquired on June 30, 2021 and 252 shares acquired on December 31, 2021 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":98491,"source":{"system":"sec-edgar","filing":"0001606498-22-000033","document":"wf-form4_164675689369870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649822000033/wf-form4_164675689369870.xml","form_type":"4"}},{"id":2777288,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-19T17:36:31.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":15861,"price":47.29,"value":750066.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual grant of time-vested restricted stock units awarded to Reporting Person on 3/17/2021, with a 3 year cliff vesting period."}],"balance_after":67244,"source":{"system":"sec-edgar","filing":"0001606036-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160603621000002/primary_doc.xml","form_type":"4"}},{"id":3154003,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-11T18:18:21.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":38187,"price":30.67,"value":1171195.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents stock options issued pursuant to the Avanos Medical, Inc. Equity Participation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award will vest 30% on May 7, 2021, 30% on May 7, 2022, and 40% on May 7, 2023, subject to earlier vesting in the event of death, disability or certain other events."}],"balance_after":38187,"derivative":{"exercise_price":30.67,"exercise_date":"2021-05-07","expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":38187},"source":{"system":"sec-edgar","filing":"0001606498-20-000036","document":"wf-form4_158923548389578.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649820000036/wf-form4_158923548389578.xml","form_type":"4"}},{"id":3154002,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-11T18:18:21.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":36681,"price":30.67,"value":1125006.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual grant of time-vested restricted stock units awarded to Reporting Person on 5/7/2020, with a 3 year cliff vesting period."}],"balance_after":51383,"source":{"system":"sec-edgar","filing":"0001606498-20-000036","document":"wf-form4_158923548389578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649820000036/wf-form4_158923548389578.xml","form_type":"4"}},{"id":3315032,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-08T15:39:55.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":14702,"price":34.01,"value":500015.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-vested restricted stock units awarded to reporting person as a new hire on 1/2/2020.  The stock units have a 3-year cliff vesting period."}],"balance_after":14702,"source":{"system":"sec-edgar","filing":"0001606498-20-000002","document":"wf-form4_157851597252765.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520392/000160649820000002/wf-form4_157851597252765.xml","form_type":"4"}},{"id":3390951,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2019-10-18T22:33:20.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":15320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":15320,"derivative":{"underlying":"Common Stock","underlying_shares":15320},"source":{"system":"sec-edgar","filing":"0001567619-19-019776","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919019776/doc1.xml","form_type":"4"}},{"id":3432926,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-08-20T22:52:46.000Z","date":"2019-08-18","kind":"tax_withholding","acquired":false,"shares":826,"price":19.1,"value":15776.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 826 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on August 18, 2016."}],"balance_after":33438,"source":{"system":"sec-edgar","filing":"0001567619-19-017367","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017367/doc1.xml","form_type":"4"}},{"id":3432921,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2019-08-20T10:08:04.000Z","date":"2019-07-12","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On August 18, 2016, the reporting person received a target grant of 20,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 10,400 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 18, 2016, the reporting person received a target grant of 20,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 10,400 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 18, 2016, the reporting person received a target grant of 20,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 10,400 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-19-017320","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017320/doc1.xml","form_type":"4"}},{"id":3432920,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-08-20T10:08:04.000Z","date":"2019-07-12","kind":"tax_withholding","acquired":false,"shares":3440,"price":21.68,"value":74579.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,440 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on August 18, 2016."}],"balance_after":34264,"source":{"system":"sec-edgar","filing":"0001567619-19-017320","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017320/doc1.xml","form_type":"4"}},{"id":3432919,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-08-20T10:08:04.000Z","date":"2019-07-12","kind":"exercise","acquired":true,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 10,400 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on August 18, 2016."}],"balance_after":37704,"source":{"system":"sec-edgar","filing":"0001567619-19-017320","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017320/doc1.xml","form_type":"4"}},{"id":3448863,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-08-02T20:22:34.000Z","date":"2019-07-26","kind":"tax_withholding","acquired":false,"shares":511,"price":20.89,"value":10674.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 511 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":27304,"source":{"system":"sec-edgar","filing":"0001567619-19-015712","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015712/doc1.xml","form_type":"4"}},{"id":3455857,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-07-25T20:59:42.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":172,"price":21.53,"value":3703.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 172 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":27815,"source":{"system":"sec-edgar","filing":"0001567619-19-015211","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015211/doc1.xml","form_type":"4"}},{"id":3455856,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-07-25T20:59:42.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":404,"price":21.53,"value":8698.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 404 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":27987,"source":{"system":"sec-edgar","filing":"0001567619-19-015211","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015211/doc1.xml","form_type":"4"}},{"id":3458418,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-07-20T01:28:31.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":25621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":25621,"derivative":{"exercise_price":21.54,"exercise_date":"2020-07-17","expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":25621},"source":{"system":"sec-edgar","filing":"0001567619-19-015041","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015041/doc1.xml","form_type":"4"}},{"id":3458417,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-07-20T01:28:31.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":7660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 7,660 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 7,660 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":28391,"source":{"system":"sec-edgar","filing":"0001567619-19-015041","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015041/doc1.xml","form_type":"4"}},{"id":3770417,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2018-11-08T21:06:19.000Z","date":"2018-11-07","kind":"sale","acquired":false,"shares":1939,"price":21.53,"value":41746.67,"ownership":{"direct":true},"balance_after":20731,"source":{"system":"sec-edgar","filing":"0001567619-18-005419","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761918005419/doc1.xml","form_type":"4"}},{"id":3859847,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2018-07-28T00:01:54.000Z","date":"2018-07-26","kind":"tax_withholding","acquired":false,"shares":511,"price":21.88,"value":11180.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 511 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":22670,"source":{"system":"sec-edgar","filing":"0001140361-18-033944","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033944/doc1.xml","form_type":"4"}},{"id":3863508,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2018-07-21T01:38:55.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":13975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":13975,"derivative":{"underlying":"Common Stock","underlying_shares":13975},"source":{"system":"sec-edgar","filing":"0001140361-18-033095","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033095/doc1.xml","form_type":"4"}},{"id":3863507,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-21T01:38:55.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":22260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 18, 2019, such that 25% of the options will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":22260,"derivative":{"exercise_price":20.93,"exercise_date":"2019-07-18","expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":22260},"source":{"system":"sec-edgar","filing":"0001140361-18-033095","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033095/doc1.xml","form_type":"4"}},{"id":3863506,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2018-07-21T01:38:55.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":6988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 6,988 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 6,988 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 18, 2019, such that 25% of the restricted stock units will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":23181,"source":{"system":"sec-edgar","filing":"0001140361-18-033095","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033095/doc1.xml","form_type":"4"}},{"id":4249276,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2017-07-28T19:08:29.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":12387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":12387,"derivative":{"underlying":"Common Stock","underlying_shares":12387},"source":{"system":"sec-edgar","filing":"0001140361-17-029083","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029083/doc1.xml","form_type":"4"}},{"id":4249275,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-07-28T19:08:29.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":21762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":21762,"derivative":{"exercise_price":16.55,"exercise_date":"2018-07-26","expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":21762},"source":{"system":"sec-edgar","filing":"0001140361-17-029083","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029083/doc1.xml","form_type":"4"}},{"id":4249274,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":79810,"kind":"person","name":"Greiner Michael","position":1,"cik":"0001520392","reported_name":"Greiner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2017-07-28T19:08:29.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":6193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 6,193 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 6,193 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":16193,"source":{"system":"sec-edgar","filing":"0001140361-17-029083","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029083/doc1.xml","form_type":"4"}}]}